Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
Authors
Keywords
-
Journal
Nature Biomedical Engineering
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-13
DOI
10.1038/s41551-018-0279-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity
- (2016) Jonathan C. Barnes et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Treatment of Patients with Cirrhosis
- (2016) Phillip S. Ge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Pathobiology of liver fibrosis: a translational success story
- (2015) Youngmin A Lee et al. GUT
- Hepatic fibrosis: Concept to treatment
- (2015) Christian Trautwein et al. JOURNAL OF HEPATOLOGY
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- PEGylated Biopharmaceuticals
- (2015) Inge A. Ivens et al. TOXICOLOGIC PATHOLOGY
- Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
- (2014) Ali A Mokdad et al. BMC Medicine
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
- (2014) Andreas Baumann et al. DRUG DISCOVERY TODAY
- A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
- (2014) Longyan Liao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nanotechnology applications for the therapy of liver fibrosis
- (2014) Lydia Giannitrapani WORLD JOURNAL OF GASTROENTEROLOGY
- Polymeric micelles as drug delivery vehicles
- (2014) Zaheer Ahmad et al. RSC Advances
- Synthesis of Acid-Labile PEG and PEG-Doxorubicin-Conjugate Nanoparticles via Brush-First ROMP
- (2014) Angela X. Gao et al. ACS Macro Letters
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
- (2013) Masato Fujii et al. Medical Molecular Morphology
- Therapy for Fibrotic Diseases: Nearing the Starting Line
- (2013) S. L. Friedman et al. Science Translational Medicine
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Polymeric Conjugates for Drug Delivery
- (2012) Nate Larson et al. CHEMISTRY OF MATERIALS
- “Brush-First” Method for the Parallel Synthesis of Photocleavable, Nitroxide-Labeled Poly(ethylene glycol) Star Polymers
- (2012) Jenny Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
- (2011) Kate M. Fleming et al. LIVER INTERNATIONAL
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Core-Clickable PEG-Branch-Azide Bivalent-Bottle-Brush Polymers by ROMP: Grafting-Through and Clicking-To
- (2010) Jeremiah A. Johnson et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Drug-Loaded, Bivalent-Bottle-Brush Polymers by Graft-through ROMP
- (2010) Jeremiah A. Johnson et al. MACROMOLECULES
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation